Go Back
Abingworth
Abingworth, a venture fund established in 1973, operates from London, United Kingdom. The fund, led by partner Tim Haines, specializes in Seed to Series D investments within the BioTech, Healthcare, and Medical Device sectors. Abingworth has backed notable companies like Wugen, Q32 Bio, and Tizona Therapeutics. With a total of 166 investments and 78 exits, Abingworth prides itself on fostering collaborations with life sciences entrepreneurs to drive innovation in the industry. For more information, visit their website at www.abingworth.com.
About
About
About
Bio
Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs.
Location
London, United Kingdom
Stage
Seed, Series A, Series B, Series C, Series D
Partner name
Tim Haines
Bio
Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs.
Location
London, United Kingdom
Stage
Seed, Series A, Series B, Series C, Series D
Partner name
Tim Haines
Fund
Fund
Fund
Fund Focus
BioTech, Healthcare, Medical Device
Number of investments
166
Number of exits
78
Fund Type
Venture Fund
Portfolio Companies
Wugen, Q32 Bio, Tizona Therapeutics
Abingworth
Abingworth, a venture fund established in 1973, operates from London, United Kingdom. The fund, led by partner Tim Haines, specializes in Seed to Series D investments within the BioTech, Healthcare, and Medical Device sectors. Abingworth has backed notable companies like Wugen, Q32 Bio, and Tizona Therapeutics. With a total of 166 investments and 78 exits, Abingworth prides itself on fostering collaborations with life sciences entrepreneurs to drive innovation in the industry. For more information, visit their website at www.abingworth.com.
About
Bio
Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs.
Location
London, United Kingdom
Stage
Seed, Series A, Series B, Series C, Series D
Partner name
Tim Haines
Fund
Fund Focus
BioTech, Healthcare, Medical Device
Number of investments
166
Number of exits
78
Fund Type
Venture Fund
Portfolio Companies
Wugen, Q32 Bio, Tizona Therapeutics